Skip to main content

16.05.2024 | RESEARCH

Peripheral Blood Lymphocyte Subsets and Heterogeneity of B Cell Subsets in Patients of Idiopathic Inflammatory Myositis with Different Myositis-specific Autoantibodies

verfasst von: Zhou Pan, Mengdi Li, Panpan Zhang, Tianqi Li, Rui Liu, Jia Liu, Shengyun Liu, Yusheng Zhang

Erschienen in: Inflammation

Einloggen, um Zugang zu erhalten

Abstract

Idiopathic inflammatory myopathies (IIM) are a group of myopathies that present with muscle weakness and multiple extra-muscular manifestations, in which lymphocytes play central roles in myositis pathogenesis. This study aimed to explore the clinical characteristics of lymphocyte subsets, especially B cell subsets, in patients with IIM. Our study included 176 patients with active IIM and 210 gender/age-matched healthy controls (HCs). Compared to HCs, patients have reduced counts of T cells, B cells, and natural killer cells. In addition, B cell subsets from 153 patients with IIM and 92 HCs were characterized. Patients had a lower percentage of memory B cells and translational memory B cells, while those patients were with an elevated percentage of CD19+ B cells, plasmablast and naïve B cells compared with HCs. Moreover, to further explore the heterogeneity of B cells in IIM, patients were categorized into three clusters based on clustering analysis. Cluster 1 was dominated by CD19+ B cells, Bregs and naïve B cells, cluster 3 was dominated by memory B cells and plasmablast, and cluster 2 had the highest proportion of translational memory B cells. Notably, patients in cluster 1 presented with higher CK levels, indicating muscle damage, whereas patients in cluster 3 showed a higher incidence of chest tightness. Our study indicated that lymphopenia is a common manifestation in patients with IIM. B cell subsets are abnormally expressed and showed high heterogeneity in patients with IIM. The patients with IIM were divided into three different clusters with different percentages of chest tightness and distinct CK levels.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
13.
18.
23.
Zurück zum Zitat Lundberg, I.E., A. Tjärnlund, M. Bottai, V.P. Werth, C. Pilkington, M. de Visser, L. Alfredsson, A.A. Amato, R.J. Barohn, M.H. Liang, et al. 2017. 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups. Arthritis & Rheumatology (Hoboken, N.J.) 69: 2271–2282. https://doi.org/10.1002/art.40320.CrossRef Lundberg, I.E., A. Tjärnlund, M. Bottai, V.P. Werth, C. Pilkington, M. de Visser, L. Alfredsson, A.A. Amato, R.J. Barohn, M.H. Liang, et al. 2017. 2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups. Arthritis & Rheumatology (Hoboken, N.J.) 69: 2271–2282. https://​doi.​org/​10.​1002/​art.​40320.CrossRef
26.
Zurück zum Zitat Isenberg, D.A., E. Allen, V. Farewell, M.R. Ehrenstein, M.G. Hanna, I.E. Lundberg, C. Oddis, C. Pilkington, P. Plotz, D. Scott, et al. 2004. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford, England) 43: 49–54. https://doi.org/10.1056/NEJM197502132920706.CrossRefPubMed Isenberg, D.A., E. Allen, V. Farewell, M.R. Ehrenstein, M.G. Hanna, I.E. Lundberg, C. Oddis, C. Pilkington, P. Plotz, D. Scott, et al. 2004. International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford, England) 43: 49–54. https://​doi.​org/​10.​1056/​NEJM197502132920​706.CrossRefPubMed
27.
Zurück zum Zitat Jin, Q., L. Fu, H. Yang, X. Chen, S. Lin, Z. Huang, B. Gao, X. Tian, W. Jiang, X. Shu, et al. 2023. Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis. Journal of Internal Medicine 293: 494–507. https://doi.org/10.1111/joim.13607.CrossRefPubMed Jin, Q., L. Fu, H. Yang, X. Chen, S. Lin, Z. Huang, B. Gao, X. Tian, W. Jiang, X. Shu, et al. 2023. Peripheral lymphocyte count defines the clinical phenotypes and prognosis in patients with anti-MDA5-positive dermatomyositis. Journal of Internal Medicine 293: 494–507. https://​doi.​org/​10.​1111/​joim.​13607.CrossRefPubMed
31.
Zurück zum Zitat Lin, S., Y. Zhang, Z. Cao, Y. Xu, Q. Jin, X. Chen, X. Shu, X. Lu, G. Wang, and Q. Peng. 2023. Decrease in cell counts and alteration of phenotype characterize peripheral NK cells of patients with anti-MDA5-positive dermatomyositis. Clinica Chimica Acta; International Journal of Clinical Chemistry 543: 117321. https://doi.org/10.1016/j.cca.2023.117321.CrossRefPubMed Lin, S., Y. Zhang, Z. Cao, Y. Xu, Q. Jin, X. Chen, X. Shu, X. Lu, G. Wang, and Q. Peng. 2023. Decrease in cell counts and alteration of phenotype characterize peripheral NK cells of patients with anti-MDA5-positive dermatomyositis. Clinica Chimica Acta; International Journal of Clinical Chemistry 543: 117321. https://​doi.​org/​10.​1016/​j.​cca.​2023.​117321.CrossRefPubMed
32.
Zurück zum Zitat Noyola, D.E., G. Juárez-Vega, C. Monjarás-Ávila, F. Escalante-Padrón, V. Rangel-Ramírez, S. Cadena-Mota, A. Monsiváis-Urenda, C.A. García-Sepúlveda, and R. González-Amaro. 2015. NK cell immunophenotypic and genotypic analysis of infants with severe respiratory syncytial virus infection. Microbiology and Immunology 59: 389–397. https://doi.org/10.1111/1348-0421.12265.CrossRefPubMed Noyola, D.E., G. Juárez-Vega, C. Monjarás-Ávila, F. Escalante-Padrón, V. Rangel-Ramírez, S. Cadena-Mota, A. Monsiváis-Urenda, C.A. García-Sepúlveda, and R. González-Amaro. 2015. NK cell immunophenotypic and genotypic analysis of infants with severe respiratory syncytial virus infection. Microbiology and Immunology 59: 389–397. https://​doi.​org/​10.​1111/​1348-0421.​12265.CrossRefPubMed
37.
Zurück zum Zitat Pelzek, A.J., C. Grönwall, P. Rosenthal, J.D. Greenberg, M. McGeachy, L. Moreland, W.F.C. Rigby, and G.J. Silverman. 2017. Persistence of disease-associated anti-citrullinated protein antibody-expressing memory B Cells in rheumatoid arthritis in clinical remission. Arthritis & Rheumatology 69: 1176–1186. https://doi.org/10.1002/art.40053.CrossRef Pelzek, A.J., C. Grönwall, P. Rosenthal, J.D. Greenberg, M. McGeachy, L. Moreland, W.F.C. Rigby, and G.J. Silverman. 2017. Persistence of disease-associated anti-citrullinated protein antibody-expressing memory B Cells in rheumatoid arthritis in clinical remission. Arthritis & Rheumatology 69: 1176–1186. https://​doi.​org/​10.​1002/​art.​40053.CrossRef
38.
Zurück zum Zitat Sugimori, Y., Y. Iwasaki, Y. Takeshima, M. Okubo, S. Kobayashi, H. Hatano, S. Yamada, M. Nakano, R. Yoshida, M. Ota, et al. 2023. Transcriptome profiling of immune cell types in peripheral blood reveals common and specific pathways involved in the pathogenesis of myositis-specific antibody-positive inflammatory myopathies. ACR Open Rheumatology. https://doi.org/10.1002/acr2.11521.CrossRefPubMedPubMedCentral Sugimori, Y., Y. Iwasaki, Y. Takeshima, M. Okubo, S. Kobayashi, H. Hatano, S. Yamada, M. Nakano, R. Yoshida, M. Ota, et al. 2023. Transcriptome profiling of immune cell types in peripheral blood reveals common and specific pathways involved in the pathogenesis of myositis-specific antibody-positive inflammatory myopathies. ACR Open Rheumatology. https://​doi.​org/​10.​1002/​acr2.​11521.CrossRefPubMedPubMedCentral
Metadaten
Titel
Peripheral Blood Lymphocyte Subsets and Heterogeneity of B Cell Subsets in Patients of Idiopathic Inflammatory Myositis with Different Myositis-specific Autoantibodies
verfasst von
Zhou Pan
Mengdi Li
Panpan Zhang
Tianqi Li
Rui Liu
Jia Liu
Shengyun Liu
Yusheng Zhang
Publikationsdatum
16.05.2024
Verlag
Springer US
Erschienen in
Inflammation
Print ISSN: 0360-3997
Elektronische ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-024-02052-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.